WebOPDIVO em monoterapia é indicado para o tratamento de doentes adultos com linfoma de Hodgkin clássico refratário ou recidivante, após transplante autólogo de progenitores … Web20 de abr. de 2024 · Bristol Myers Squibb Co said on Monday that its blockbuster cancer immunotherapy Opdivo performed well in two separate late-stage trials, prolonging survival in previously untreated patients with ...
Products and Medicines - Bristol Myers Squibb
Web329.09.2016 Bristol-Myers Squibb Company Opdivo (nivolumab) Oncologie OPDIVO este indicat ca monoterapie pentru tratamentul carcinomului renal după terapie anterioară, la adulți 1.Spitalul Judetean de Urgnta Dr C-tin Opris, Baia Mare 2. Spital Judetean de urgentă Baia Mare Aut n 3/.04.04.2016 Program inchis 422.07.2016 Pfizer Romania S.R.L. WebBristol-Myers Squibb Pharma EEIG. Official address: Uxbridge Business Park, Sanderson Road . Uxbridge, Middlesex UB8 1DH . United Kingdom . Registered in England and … iris thalhammer
Opdivo: Withdrawn application European Medicines Agency
Web20 de mai. de 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of completely resected esophageal or gastroesophageal junction (GEJ) cancer with … WebBristol-Myers Squibb Pharma EEIG Version 3.0 Confidential and Proprietary 1 EURISK MANAGEMENT PLANFOR ZEPOSIA(OZANIMOD) VERSION 3.0,18 OCT2024. EDMS Doc. Number: 25854716 - 25854236 Zeposia EMEA/H/C/004835 Bristol-Myers Squibb Pharma EEIG Version 3.0/Part I WebLéčivý přípravek: OPDIVO 10MG/ML INF CNC SOL 1X4ML. OPDIVO 10MG/ML INF CNC SOL 1X10ML. OPDIVO 10MG/ML INF CNC SOL 1X24ML. OPDIVO 10MG/ML INF CNC SOL 1X12ML. Držitel rozhodnutí o registraci: Bristol-Myers Squibb Pharma EEIG iris texas tech el paso